PRODUCT DETAILS

About Forstavir 200 mg/300 mg/600 mg Tablet

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ belongs to the class of medicines called ‘antiretroviral agents’ used to treat HIV infection. HIV is a virus that attacks the immune cells of the body leading to decreased immunity. It spreads through body fluids such as semen, vaginal fluid, and blood. Symptoms include fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat that usually last for days to several weeks.

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ contains Emtricitabine, Tenofovir Disoproxil Fumarate and Efavirenz. Efavirenz is a non-nucleoside reverse transcriptase inhibitor, Emtricitabine is a nucleoside reverse transcriptase inhibitor and Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor. They work by inhibiting the reverse transcriptase enzyme production, which is necessary for the multiplication of the viruses. This effect helps to inhibit viral replication.

You should take this medicine exactly as prescribed by the doctor. The common side-effects of EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ are dizziness, headache, diarrhea, nausea, vomiting, rashes (red spots or blotches sometimes with blistering and swelling of the skin), and feeling weak. These side-effects usually resolve without requiring any medical attention. However, if any of these side effects persist or worsen, inform your doctor immediately.

It is not recommended to take EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ if you are allergic to any contents of it. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ is not recommended for use in lactating mothers, children, and adolescents under 18 years of age. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy. Consumption of alcohol may increase the risk of side effects, therefore avoid alcohol consumption.

Uses of Forstavir 200 mg/300 mg/600 mg Tablet

HIV infection

Medicinal Benefits of Forstavir 200 mg/300 mg/600 mg Tablet

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ belongs to the group of medicines called antiretroviral therapy. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ contains Emtricitabine, Tenofovir Disoproxil Fumarate and Efavirenz. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ works by inhibiting the reverse transcriptase enzyme production, which is necessary for the multiplication of the viruses. This effect helps to inhibit viral replication and treats HIV infection.

Directions for Use

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should be swallowed as a whole with a glass of water. Do not crush, chew, or break it. It should be taken on an empty stomach 1 hour before or 2 hours after a meal, preferably at bedtime. Your doctor will prescribe the dose and duration based on your health condition.

Side Effects of Forstavir 200 mg/300 mg/600 mg Tablet

• Dizziness
• Headache
• Diarrhea
• Nausea
• Vomiting
• Rashes
• Feeling weak
• Loss of appetite

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should be used with caution in patients with mental illness, fits, and liver diseases. If you notice any signs of infection, inform your doctor immediately. Autoimmune diseases (immune cells attack healthy body tissue) may occur months after the start of the treatment. Inform your doctor if you notice any signs such as muscle weakness, weakness in the hands and the feet, palpitations (pounding heart), and tremors. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ may cause osteonecrosis (death of bone tissue due to a decrease in blood supply to the bone) in some patients. The risk of this disease depends on factors such as length of antiretroviral therapy, alcohol use, steroid use, body mass index (BMI), and immunity. Inform your doctor if you notice joint pain, stiffness, and difficulty in movement, as these symptoms may indicate osteonecrosis.

Drug Interactions

Drug-Drug Interaction:

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should not be taken along with antiallergic medicines (astemizole, terfenadine), a medicine used to treat heart disease (bepridil), a medicine used to treat heartburn (cisapride), medicines used to treat hepatitis C (elbasvir, grazoprevir), medicines used to treat migraine (ergotamine, dihydroergotamine, ergonovine), medicines used to treat mental illnesses (pimozide, imipramine, clomipramine), herbal medicine to treat depression (Hypericum perforatum), anti-fungal agent (voriconazole), medicines used to treat irregular heartbeats (flecainide, metoprolol), antibiotic (imidazole) and opioid pain killer (methadone).

Drug-Disease Interaction:

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should not be used in patients with severe liver disease, moderate to severe kidney disease, or heart conditions such as prolonged QT interval, which increases the risk of severe heart rhythm problems, and low electrolyte levels.

Safety Advice

ALCOHOL

Avoid consumption of alcohol as it may increase the risk of side effects.

PREGNANCY

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should be used with caution in pregnant women. It is given only if clinically needed and when benefits outweigh the risk.

BREAST FEEDING

Avoid breastfeeding during treatment with EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ.

DRIVING

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy.

LIVER

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should not be used in patients with severe liver diseases. In mild to moderate conditions, the dose may have to be adjusted by your doctor as required.

KIDNEY

EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ should not be used in patients with moderate to severe kidney diseases as this medicine may affect kidney function. In mild conditions, the dose may have to be adjusted by your doctor as required.